<?xml version="1.0" encoding="UTF-8"?>
<p>Dosage: at present, for adults, the recommended dosage is a single loading dose of 200 mg on day one followed by a once-daily maintenance dose of 100 mg from day two. For pediatric patients weighing 3.5 kg to less than 40 kg, RDV should be injected as 100 mg, lyophilized powder only. For pediatric patients weighing 40 kg and higher, the adult dosage regimen of a single loading dose of 200 mg on day one followed by once-daily maintenance doses of 100 mg from day two is recommended [
 <xref rid="REF16" ref-type="bibr">16</xref>]. On June 22, 2020, Gilead announced that the company is about to start human trials on an inhaled version of the drug for easier administration outside the hospital in the early stages of the disease [
 <xref rid="REF17" ref-type="bibr">17</xref>].
</p>
